4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075197
Director bought 409,090 shares at $11.00 ($4,499,990)
- Director acquired 1,880,390 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mehra Anand Director | 2015-10-13 | Conversion | +1,880,390 | 1,880,390 | I: show line 1 in the form | ||
| Mehra Anand Director | 2015-10-13 | Purchase | +409,090 | $11.00 | $4,499,990 | 2,289,480 | I: show line 2 in the form |
| Open-market purchases · 409,090 sh · avg $11.00 · $4,499,990 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mehra Anand Director | 2015-10-13 | Conversion · Series A Preferred Stock | −2,000,000 | 0 | I: show line 3 in the form | |||||
| Mehra Anand Director | 2015-10-13 | Conversion · Series B Preferred Stock | −2,424,242 | 0 | I: show line 4 in the form | |||||
| Mehra Anand Director | 2015-10-13 | Conversion · Series C Preferred Stock | −2,063,107 | 0 | I: show line 5 in the form |
Loading xslF345X03/doc4.xml…